The Importance of Linkers in the Structure of PSMA Ligands

Cancer is one of the leading social problems of the modern world. Today prostate cancer is the second leading cause of cancer deaths among men. Targeted drug delivery is widely used to treat and diagnose prostate cancer. Conjugates selectively binding to prostatespecific membrane antigen-based on ur...

Full description

Saved in:
Bibliographic Details
Published inCurrent medicinal chemistry Vol. 29; no. 2; p. 268
Main Authors Uspenskaya, Anastasia A, Nimenko, Ekaterina A, Machulkin, Aleksei E, Beloglazkina, Elena K, Majouga, Alexander G
Format Journal Article
LanguageEnglish
Published United Arab Emirates 2022
Subjects
Online AccessGet more information

Cover

Loading…
Abstract Cancer is one of the leading social problems of the modern world. Today prostate cancer is the second leading cause of cancer deaths among men. Targeted drug delivery is widely used to treat and diagnose prostate cancer. Conjugates selectively binding to prostatespecific membrane antigen-based on urea ligands are being actively developed against this disease. The linker has a significant influence on the biological activity of such conjugates. The linker performs a large number of functions, and its modification is one of the key methods for creating the best pharmacological profile. This review aims to discuss and analyze the main approaches to the method of introduction and synthesis of linkers for this type of conjugates without a description of the influence of biologically active molecules, as well as to establish the key modification methods that have a significant role on the structure-activity relationship. For this purpose, a review of the current scientific literature was performed, both for the conjugates under development and those already undergoing clinical trials. It was found that the optimal structure is a linker containing an aliphatic fragment near the vector- molecule (n(CH2) = 3-6), followed by a polypeptide chain consisting of 2 to 4 amino acid residues. The presence of a Phe-Phe dipeptide chain or the introduction of negatively charged groups also has a positive effect. Ongoing research in this field helps to establish the accurate effect of each linker fragment, and the development of solid-phase synthesis methods makes it much easier to achieve this goal.
AbstractList Cancer is one of the leading social problems of the modern world. Today prostate cancer is the second leading cause of cancer deaths among men. Targeted drug delivery is widely used to treat and diagnose prostate cancer. Conjugates selectively binding to prostatespecific membrane antigen-based on urea ligands are being actively developed against this disease. The linker has a significant influence on the biological activity of such conjugates. The linker performs a large number of functions, and its modification is one of the key methods for creating the best pharmacological profile. This review aims to discuss and analyze the main approaches to the method of introduction and synthesis of linkers for this type of conjugates without a description of the influence of biologically active molecules, as well as to establish the key modification methods that have a significant role on the structure-activity relationship. For this purpose, a review of the current scientific literature was performed, both for the conjugates under development and those already undergoing clinical trials. It was found that the optimal structure is a linker containing an aliphatic fragment near the vector- molecule (n(CH2) = 3-6), followed by a polypeptide chain consisting of 2 to 4 amino acid residues. The presence of a Phe-Phe dipeptide chain or the introduction of negatively charged groups also has a positive effect. Ongoing research in this field helps to establish the accurate effect of each linker fragment, and the development of solid-phase synthesis methods makes it much easier to achieve this goal.
Author Machulkin, Aleksei E
Uspenskaya, Anastasia A
Beloglazkina, Elena K
Nimenko, Ekaterina A
Majouga, Alexander G
Author_xml – sequence: 1
  givenname: Anastasia A
  surname: Uspenskaya
  fullname: Uspenskaya, Anastasia A
  organization: Department of Chemistry, M. V. Lomonosov Moscow State University, Moscow,Russian Federation
– sequence: 2
  givenname: Ekaterina A
  surname: Nimenko
  fullname: Nimenko, Ekaterina A
  organization: Department of Chemistry, M. V. Lomonosov Moscow State University, Moscow,Russian Federation
– sequence: 3
  givenname: Aleksei E
  surname: Machulkin
  fullname: Machulkin, Aleksei E
  organization: Department of Chemistry, M. V. Lomonosov Moscow State University, Moscow,Russian Federation
– sequence: 4
  givenname: Elena K
  surname: Beloglazkina
  fullname: Beloglazkina, Elena K
  organization: Department of Chemistry, M. V. Lomonosov Moscow State University, Moscow,Russian Federation
– sequence: 5
  givenname: Alexander G
  surname: Majouga
  fullname: Majouga, Alexander G
  organization: Department of Chemistry, M. V. Lomonosov Moscow State University, Moscow,Russian Federation
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34348608$$D View this record in MEDLINE/PubMed
BookMark eNo1j8tKxEAURBtRnIf-gsQPiN6-ye10uxsGRwciCjOCu6Ff0ajphE6y8O8NPlYFdQ4FtWDHoQ2esUsOV8iL_BoUKimKDKUQAjlIyKcKAY7YnMuCUsqylxlb9P07AEcFcMpmWZ7lUoCcs5v9m0-2TdfGQQfrk7ZKyjp8-NgndUiGCe6GONphjD_safewmoRXHVx_xk4q_dn7879csufN7X59n5aPd9v1qkwNgRxS5yQSWF1ZIKvIcCKFRhNx4R1yBElGSSyEJE_agVaq4txzcMJUVgIu2cXvbjeaxrtDF-tGx6_D_wn8BlarSTE
CitedBy_id crossref_primary_10_1007_s00044_022_03002_w
crossref_primary_10_1021_acs_jpcc_2c05415
crossref_primary_10_1134_S1070428024080013
crossref_primary_10_31857_S0320972523070084
crossref_primary_10_1021_acs_bioconjchem_1c00537
crossref_primary_10_1134_S0006297923070088
crossref_primary_10_2147_OTT_S485869
crossref_primary_10_31857_S0514749224020058
crossref_primary_10_1021_acs_jmedchem_1c01157
crossref_primary_10_3390_ijms241411327
ContentType Journal Article
Copyright Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Copyright_xml – notice: Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.2174/0929867328666210804092200
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
Chemistry
Pharmacy, Therapeutics, & Pharmacology
EISSN 1875-533X
ExternalDocumentID 34348608
Genre Journal Article
Review
GrantInformation_xml – fundername: Russian Foundation for Basic Research (RFBR)
  grantid: 19-33-90118
GroupedDBID ---
.5.
0R~
29F
36B
4.4
53G
5GY
7X7
88E
88I
8AO
8FE
8FG
8FH
8FI
8FJ
8R4
8R5
AAEGP
AAVXF
ABEEF
ABJCF
ABJNI
ABMOS
ABUWG
ABVDF
ACGFS
ACGOD
ACITR
ACIWK
ACPRK
ACZAY
ADBBV
AENEX
AEUYN
AFHZU
AFKRA
AFRAH
AFUQM
AGJNZ
AGQPQ
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ANTIV
AZQEC
BENPR
BGLVJ
BPHCQ
BVXVI
C1A
CCPQU
CGR
CS3
CUY
CVF
D1I
DU5
DWQXO
EBS
ECM
EIF
EJD
F5P
FYUFA
GH2
GNUQQ
HCIFZ
HMCUK
HZ~
IPNFZ
KB.
KCGFV
KFI
LK5
M1P
M2P
M7R
NPM
O9-
P2P
PDBOC
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
Q2X
RIG
UKHRP
ID FETCH-LOGICAL-b508t-dd8250cafc05c95b15592ba5516ed212085b9827685e5ad0a99f11e10d6bfc802
IngestDate Mon Jul 21 05:38:32 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords linker
target drug delivery
PSMA
linker’s structure
spacer
Prostate cancer
synthesis of conjugates
Language English
License Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-b508t-dd8250cafc05c95b15592ba5516ed212085b9827685e5ad0a99f11e10d6bfc802
PMID 34348608
ParticipantIDs pubmed_primary_34348608
PublicationCentury 2000
PublicationDate 2022-00-00
PublicationDateYYYYMMDD 2022-01-01
PublicationDate_xml – year: 2022
  text: 2022-00-00
PublicationDecade 2020
PublicationPlace United Arab Emirates
PublicationPlace_xml – name: United Arab Emirates
PublicationTitle Current medicinal chemistry
PublicationTitleAlternate Curr Med Chem
PublicationYear 2022
SSID ssj0012900
Score 2.4149938
SecondaryResourceType review_article
Snippet Cancer is one of the leading social problems of the modern world. Today prostate cancer is the second leading cause of cancer deaths among men. Targeted drug...
SourceID pubmed
SourceType Index Database
StartPage 268
SubjectTerms Cell Line, Tumor
Drug Delivery Systems
Humans
Ligands
Male
Peptides - therapeutic use
Prostatic Neoplasms - drug therapy
Structure-Activity Relationship
Title The Importance of Linkers in the Structure of PSMA Ligands
URI https://www.ncbi.nlm.nih.gov/pubmed/34348608
Volume 29
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEB6cFtxcSuq-m5QtlJyiVtpIqtSbE1LSFodAbPAtzD6UGjuKwc7B-QP9253RrixhGvq4CKGRhNCMVvPN4xuA9xZtphNlA8yNDmJySQJMJdlySn-PRCulqjjk4Cw9HcXfxsm40_nZqlq6XaoP-u63fSX_o1U6RnrlLtl_0Oz6pnSA9km_tCUN0_avdfz1uvKg-fvkcD9BS27J9dWLFxU7LOcIuNTtYtCnE67q5t41QYGnaPJpdiYMqafA1eoYLeYEd6e4clHYEsmnXEywCYSe8ZCAaRV2PZki8z-XLekA9Y_bmR_81Z_Z6cJOmhaII0vr7wzvSI6u0szSxd_b8QgpW_EI69ZQgkABeZHj9iLrwxqTFtb1K6abqrO5kjNSqhJLMs9SJhQimCW5HpLwqHTkpsuWhufXlYoP40MeqpX9WbpBsl2LtmCL4AbPT-Wgj09GyTwMu_DOP9XHe59pG7r1fTZASuWsDHfgsUcZou9M5gl0bNmDR8e1WnvQHfiaih7snzv28tWBGDbNeIsDsS_OG17z1VP4TGLRmJu4KYQ3NzEpBZmbWJsby9jchDe3ZzD6cjI8Pg386I1Akce-DIzJyDfWWOgw0XmiOHktFXJW1RrydshRV3kmCasmNkETYp4XUWSj0KSq0Fkon8OD8qa0L0FEMdLPPcI0tipG_KRMlhiMVS5NHFqpX8EL96ou545f5bJ-ia_vlbyB7cb0duFhQR-03SPvcKneVrr7Bc1UYJ0
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Importance+of+Linkers+in+the+Structure+of+PSMA+Ligands&rft.jtitle=Current+medicinal+chemistry&rft.au=Uspenskaya%2C+Anastasia+A&rft.au=Nimenko%2C+Ekaterina+A&rft.au=Machulkin%2C+Aleksei+E&rft.au=Beloglazkina%2C+Elena+K&rft.date=2022-01-01&rft.eissn=1875-533X&rft.volume=29&rft.issue=2&rft.spage=268&rft_id=info:doi/10.2174%2F0929867328666210804092200&rft_id=info%3Apmid%2F34348608&rft_id=info%3Apmid%2F34348608&rft.externalDocID=34348608